Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation of Prevalence of and Risk Factor for Respiratory Viruses Among Emergently Admitted Adult Patients With Respiratory Symptoms and Their Influence on Clinical Outcomes in the Settings From Rural to Urban Community Hospitals

NCT05913700 is registered in ClinicalTrials.gov with Institute for Clinical Effectiveness, Japan as lead sponsor.

NCT NCT05913700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05913700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation of Prevalence of and Risk Factor for Respiratory Viruses Among Emergently Admitted Adult Patients With Respiratory Symptoms and Their Influence on Clinical Outcomes in the Settings From Rural to Urban Community Hospitals
Lead sponsor
Institute for Clinical Effectiveness, Japan
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2023
Completion date
September 30, 2026
Enrollment
3,067 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute disease, respiratory syncytial virus (rsv), respiratory viral infection